Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern

Completed

Conditions studied: Angina Pectoris, Coronary Artery Disease, Chest Pain, Cardiovascular Diseases, Coronary Heart Disease, CAD, CVD, CHD

In brief

To investigate whether the use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood assay changes the diagnostic testing pattern in patients referred to a cardiologist for the evaluation of chest pain or anginal equivalent symptoms.

Key facts

Study ID

NCT01251302

Run by

CardioDx

People needed

171

Starts

2010-11-01

Expected to finish

2012-06-01

Last updated by the study team

2019-01-31

Who can join

Age: 21 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stable chest pain, typical or atypical angina or anginal equivalent
• The patient has signed the appropriate Institutional Review Board approved Informed Consent Form.

You may not qualify if…

• History of myocardial infarction
• Current myocardial infarct (MI) or acute coronary syndrome
• Current New York Heart Association (NYHA) class III or IV congestive heart failure symptoms
• Any previous coronary revascularization
• Any individuals with:
• Diabetes
• Suspected unstable angina
• Systemic infections
• Systemic inflammatory conditions
• Any individuals currently taking:
• Steroids
• Immunosuppressive agents
• Chemotherapeutic agents
• Recipient of any organ transplant

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.